Laser-assisted Immunotherapy is an experimental immunotherapy for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses. Specifically, laser-assisted immunotherapy combines laser-induced in situ tumor devitalization with an immunoadjuvant for local immunostimulation.

Experimental data and initial human trials suggests that laser-assisted immunotherapy treatment may prolong life and even cure patients with advanced cancer. It thus offers a fresh approach to a disease for which current treatment options are severely limited.

The treatment is minimally invasive, highly affordable, and our studies indicate that it is entirely non-toxic. Thus, our protocol will be easily integrated into small-scale clinics virtually anywhere in the world.

Immunophotonics holds all patents for both the method and associated immunoadjuvant.